HollandR, HendriksJH, MravunacM. Mammographically occult breast cancer. A pathologic and radiologic study. Cancer, 1983; 52:1810–1819.
2.
CarneyPA, MigliorettiDL, YankaskasBC, et al.Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med, 2003; 138:168–175.
3.
KerlikowskeK, CookAJ, BuistDS, et al.Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use. J Clin Oncol, 2010; 28:3830–3837.
4.
KelemenLE, PankratzVS, SellersTA, et al.Age-specific trends in mammographic density: The Minnesota Breast Cancer Family Study. Am J Epidemiol, 2008; 167:1027–1036.
5.
BrandJS, CzeneK, ErikssonL, et al.Influence of lifestyle factors on mammographic density in postmenopausal women. PLoS One, 2013; 8:e81876.
6.
BoydNF, MartinLJ, SunL, et al.Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 2006; 15:2086–2092.
7.
BurnsideES, SicklesEA, BassettLW, et al.The ACR BI-RADS experience: Learning from history. J Am Coll Radiol, 2009; 6:851–860.
8.
CappelloNM, RichetelliD, LeeCI. The impact of breast density reporting laws on women's awareness of density-associated risks and conversations regarding supplemental screening with providers. J Am Coll Radiol, 2019; 16:139–146.
9.
OzanneEM, DrohanB, BosinoffP, et al.Which risk model to use? Clinical implications of the ACS MRI screening guidelines. Cancer Epidemiol Biomarkers Prev, 2013; 22:146–149.
10.
WarwickJ, BirkeH, StoneJ, et al.Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: Findings from the placebo arm of the International Breast Cancer Intervention Study I. Breast Cancer Res, 2014; 16:451.
11.
AmirE, FreedmanOC, SerugaB, EvansDG. Assessing women at high risk of breast cancer: A review of risk assessment models. J Natl Cancer Inst, 2010; 102:680–691.
12.
ScheelJR, LeeJM, SpragueBL, LeeCI, LehmanCD. Screening ultrasound as an adjunct to mammography in women with mammographically dense breasts. Am J Obstet Gynecol, 2015; 212:9–17.
13.
CiattoS, HoussamiN, BernardiD, et al.Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): A prospective comparison study. Lancet Oncol, 2013; 14:583–589.
14.
BergWA, BlumeJD, CormackJB, et al.Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA, 2008; 299:2151–2163.
15.
ConantEF, BarlowWE, HerschornSD, et al.Association of digital breast tomosynthesis vs digital mammography with cancer detection and recall rates by age and breast density. JAMA Oncol, 2019; 5:635–642.
16.
TostesonANA. An abbreviated MRI protocol for breast cancer screening in women with dense breasts: Promising results, but further evaluation required prior to widespread implementation. JAMA, 2020; 323:719–721.
17.
HruskaCB. Molecular breast imaging for screening in dense breasts: State of the art and future directions. AJR Am J Roentgenol, 2017; 208:275–283.
18.
RhodesDJ, HruskaCB, ConnersAL, et al.Journal club: Molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts. AJR Am J Roentgenol, 2015; 204:241–251.
19.
SiuAL, Bibbins-DomingoK, GrossmanDC, LeFevreML. Convergence and divergence around breast cancer screening. Ann Intern Med, 2016; 164:301–302.
